Evidence map›Paper›PMID 38228467›Full record

ArticleJournal of clinical lipidology

Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.

Laney K Jones, Katrina M Romagnoli, Tyler J Schubert, Katarina Clegg, H Lester Kirchner, Yirui Hu, Dylan Cawley, Victoria Norelli, Marc S Williams, Samuel S Gidding and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical lipidology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05284513 (Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05284513 naenrolling by invitationnot on this map

Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)

TypeinterventionalSponsorGeisinger ClinicRan2022 to 2027Enrolled532ConditionsFamilial HypercholesterolemiaArmsFH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance
3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: A mixed methods study.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laney K JonesDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm); Heart and Vascular Institute, Geisinger, Danville, PA 17822, USA (Drs Jones). Electronic address: https://twitter.com/LaneyJonesRx.
Katrina M RomagnoliDepartment of Population Health Sciences, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Romagnoli, Kirchner and Hu).
Tyler J SchubertDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm); Geisinger Commonwealth School of Medicine, Scranton, PA 18510, USA (Drs Schubert and Clegg).
Katarina CleggDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm); Geisinger Commonwealth School of Medicine, Scranton, PA 18510, USA (Drs Schubert and Clegg).
H Lester KirchnerDepartment of Population Health Sciences, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Romagnoli, Kirchner and Hu).
Yirui HuDepartment of Population Health Sciences, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Romagnoli, Kirchner and Hu).
Dylan CawleyDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm).
Victoria NorelliDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm).
Marc S WilliamsDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm).
Samuel S GiddingDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm).
Alanna K RahmDepartment of Genomic Health, Research Institute, Geisinger, Danville, PA 17822, USA (Drs Jones, Schubert, Clegg, Cawley, Norelli, Williams, Gidding and Rahm).

Funding

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FHR33HL161775 · NHLBI · GEISINGER CLINIC · PI Samuel S Gidding · 2023 to 2026
$2.9M
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FHR61HL161775 · NHLBI · GEISINGER CLINIC · PI GIDDING, SAMUEL S, JONES, LANEY K · 2022 to 2022
$423k
NHLBI NIH HHS R33 HL161775NHLBI NIH HHS R61 HL161775
6 · The paper itself

Abstract

backgroundWe designed the Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia (CARE-FH) clinical trial to improve FH screening in primary care and facilitate guideline-based care.

objectiveThe goal was to incorporate perspectives from end-users (healthcare system leaders, primary care clinicians, cardiologists, genetic counselors, nurses, and clinic staff) and improve translation of screening guidance into practice.

methodsWe partnered with end-users to sequentially define the current state of FH screening, assess acceptability, feasibility, and appropriateness of implementing an FH screening program, and select clinically actionable strategies at the patient-, clinician-, and system-level to be deployed as a package in the CARE-FH clinical trial. Methods informed by implementation science and human centered design included: contextual inquiries, surveys, and deliberative engagement sessions.

resultsScreening for FH occurred rarely in primary care, and then only after a cardiovascular event or sometimes due to a family history of high cholesterol or early heart attack. Surveys suggested FH screening in primary care was acceptable, appropriate, and feasible. Reported and observed barriers to screening include insufficient time at patient encounters to screen, cost and convenience of testing for patients, and knowledge regarding causes of dyslipidemia. Facilitators included clear guidance on screening criteria and new therapies to treat FH. These results led to the development of multilevel strategies that were presented to end-users, modified, and then pilot tested in one primary care clinic.

conclusionsA refined implementation strategy package for FH screening was created with a goal of improving FH awareness, identification, and initiation of guideline-based care. CLINICAL

trial registrationhttps://clinicaltrials.gov/study/NCT05284513?id=NCT05284513&rank=1 Unique Identifier: NCT05284513.

Indexed as

Hyperlipoproteinemia Type IIImplementation ScienceMass ScreeningPrimary Health CareAdultFemaleHumansMaleMiddle AgedFamilial hypercholesterolemiaHuman centered designIdentificationImplementation scienceImplementation strategies

Identifiers

PMID38228467
PMCPMC11069448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.